NCT06920953 (UTP Washout) is a clinical trial in Catheter Associated Urinary Tract Infection, sponsored by B. Braun Ltd. Centre of Excellence Infection Control.

Who is sponsoring NCT06920953?

NCT06920953 is sponsored by B. Braun Ltd. Centre of Excellence Infection Control.

What condition does NCT06920953 study?

NCT06920953 studies Catheter Associated Urinary Tract Infection.

Is NCT06920953 still recruiting?

NCT06920953 is currently not yet recruiting. Last updated 10 April 2025.

Last reviewed 2025-04-10 · How we verify

NCT06920953: UTP Washout

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Participant Satisfaction and Quality of Life With Catheter Washouts in Adults Living With Long-Term Catheters and Currently Using Uro-Tainer® Polihexanide 0.02%

Not yet recruiting Last updated 10 April 2025

What this trial tests

trial in Catheter Associated Urinary Tract Infection in 50 participants. Not yet recruiting.

Timeline

1 May 2025

Primary endpoint
31 December 2025

28 February 2026

Quick facts

Lead sponsor	B. Braun Ltd. Centre of Excellence Infection Control
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 May 2025
Primary completion	31 December 2025
Estimated completion	28 February 2026

Conditions studied

Catheter Associated Urinary Tract Infection — all drugs for Catheter Associated Urinary Tract Infection →

Sponsor

B. Braun Ltd. Centre of Excellence Infection Control — full company profile →

Who can join

18 and older, any sex, with Catheter Associated Urinary Tract Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Uro-Tainer® Polihexanide 0.02% (acronym: UTP washout) is a sterile, single-use, water-based solution (100 ml) currently used in clinical practice in the UK (and Europe) for the irrigation of Long-Term-Catheter. This medical device is intended for the maintenance of indwelling urethral and suprapubic Long-Term-Catheter to aid removal of deposits, tissue waste, clots, and mucus. In this study of people living with Long-Term-Catheter and currently using UTP washouts as part of their standard clinical care, the following will be investigated : * Participant satisfaction with their UTP washout * Impact of UTP washout plan on their QoL * Adverse events (blockage, SCAUTI, others) * Participant adherence to their current washout frequency plan. This is an observational study. The participants are those currently using UTP washouts as prescribed by their clinical care team. There will be no change in treatment for study purposes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other B. Braun Ltd. Centre of Excellence Infection Control trials

Trials by the same sponsor.

NCT04902651 — HM242-Gel vs Comparator · NA · terminated
NCT04192123 — Open-Label Test of the HM242 Medical Devices to Evaluate Safety and Local Tolerability · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06920953 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by B. Braun Ltd. Centre of Excellence Infection Control
Last refreshed: 10 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06920953.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing